ID29350A - Komposisi farmasi untuk pelepasan terus menerus dan metode pelepasan zat aktif farmasi - Google Patents

Komposisi farmasi untuk pelepasan terus menerus dan metode pelepasan zat aktif farmasi

Info

Publication number
ID29350A
ID29350A IDW20010807A ID20010807A ID29350A ID 29350 A ID29350 A ID 29350A ID W20010807 A IDW20010807 A ID W20010807A ID 20010807 A ID20010807 A ID 20010807A ID 29350 A ID29350 A ID 29350A
Authority
ID
Indonesia
Prior art keywords
pharmaceutical
active release
pharmaceutical composition
release methods
continuous disposal
Prior art date
Application number
IDW20010807A
Other languages
English (en)
Indonesian (id)
Inventor
Rajen Shah
Arun P Patel
Roy T Sandry
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22627919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID29350(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID29350A publication Critical patent/ID29350A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20010807A 1998-10-14 1999-10-12 Komposisi farmasi untuk pelepasan terus menerus dan metode pelepasan zat aktif farmasi ID29350A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17249198A 1998-10-14 1998-10-14

Publications (1)

Publication Number Publication Date
ID29350A true ID29350A (id) 2001-08-23

Family

ID=22627919

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010807A ID29350A (id) 1998-10-14 1999-10-12 Komposisi farmasi untuk pelepasan terus menerus dan metode pelepasan zat aktif farmasi

Country Status (30)

Country Link
EP (1) EP1121116B1 (fr)
JP (2) JP2002527388A (fr)
KR (1) KR100517090B1 (fr)
CN (1) CN1196481C (fr)
AR (2) AR020780A1 (fr)
AT (1) ATE382345T1 (fr)
AU (1) AU765475B2 (fr)
BR (1) BR9911648A (fr)
CA (1) CA2346868C (fr)
CO (1) CO5140079A1 (fr)
CY (1) CY1107874T1 (fr)
DE (1) DE69937891T2 (fr)
DK (1) DK1121116T3 (fr)
ES (1) ES2297936T3 (fr)
HK (1) HK1040920B (fr)
HU (1) HUP0104268A3 (fr)
ID (1) ID29350A (fr)
IL (2) IL142375A0 (fr)
MY (1) MY121105A (fr)
NO (1) NO327285B1 (fr)
NZ (1) NZ511010A (fr)
PE (1) PE20001110A1 (fr)
PL (1) PL198850B1 (fr)
PT (1) PT1121116E (fr)
RU (1) RU2259826C2 (fr)
SK (2) SK286596B6 (fr)
TR (1) TR200101088T2 (fr)
TW (1) TW577738B (fr)
WO (1) WO2000021525A2 (fr)
ZA (1) ZA200103001B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569461B1 (en) 1999-03-08 2003-05-27 Merck & Co., Inc. Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
US6242003B1 (en) * 2000-04-13 2001-06-05 Novartis Ag Organic compounds
AU2000250960A1 (en) 2000-06-09 2001-12-17 Lek Pharmaceuticals D.D. Stable pharmaceutical product and formulation
JP5049450B2 (ja) * 2000-09-29 2012-10-17 アボツト・ヘルスケア・プロダクツ・ベー・ブイ イオン強度に依存しない徐放性製薬組成物
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
US20060039974A1 (en) * 2002-09-11 2006-02-23 Takeda Pharmaceutical Company Limited Sustained release preparation
EP1615619A2 (fr) 2003-04-23 2006-01-18 Ferring B.V. Sachet pour composition pharmaceutique
US8987322B2 (en) 2003-11-04 2015-03-24 Circ Pharma Research And Development Limited Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
KR100582347B1 (ko) * 2004-12-30 2006-05-22 한미약품 주식회사 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
EP1940391A4 (fr) * 2005-08-05 2010-01-20 Orbus Pharma Inc Compositions pharmaceutiques a liberation prolongee, stabilisees, comprenant un inhibiteur de l'hmg-coa reductase
WO2007100822A2 (fr) * 2006-02-24 2007-09-07 Teva Pharmaceutical Industries Ltd. Compositions pharmaceutiques de fluvastatine sodique
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
CN102805739B (zh) * 2012-04-10 2013-08-14 宋芸 氟伐他汀钠缓释包衣滴丸及其制备方法
BR112015016322A8 (pt) * 2013-01-09 2018-01-23 Edgemont Pharmaceuticals Llc formulações de liberação controlada de lorazepam
CN106344535B (zh) * 2016-08-29 2019-09-20 济南康和医药科技有限公司 一种氟伐他汀钠微孔渗透泵控释片及其制备方法
SG11202005016SA (en) 2017-12-05 2020-06-29 Sunovion Pharmaceuticals Inc Nonracemic mixtures and uses thereof
WO2019113084A1 (fr) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Formes cristallines et leurs procédés de production
SG11202102204PA (en) 2018-09-25 2021-04-29 Ponce De Leon Health Designated Activity Company Process of making calcium alpha-ketoglutarate
KR20220018004A (ko) 2019-06-04 2022-02-14 선오비온 파마슈티컬스 인코포레이티드 조절 방출 제형 및 이의 용도
WO2020252014A1 (fr) * 2019-06-10 2020-12-17 Ponce De Leon Health, Inc. Compositions à libération prolongée d'alpha-cétoglutarate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
CA2045428A1 (fr) * 1990-06-26 1991-12-27 Alfred W. Alberts Methode pour favoriser la reduction de la cholesterolemie
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
PL186907B1 (pl) * 1995-12-22 2004-03-31 Kowa Co Kompozycja farmaceutyczna stabilizowana czynnikiem zasadowym
SE9603667D0 (sv) * 1996-10-08 1996-10-08 Astra Ab Pharmaceutical compositions

Also Published As

Publication number Publication date
PL198850B1 (pl) 2008-07-31
SK5092001A3 (en) 2001-09-11
EP1121116A2 (fr) 2001-08-08
PE20001110A1 (es) 2000-11-01
BR9911648A (pt) 2001-03-20
AU765475B2 (en) 2003-09-18
AU6090999A (en) 2000-05-01
DK1121116T3 (da) 2008-05-13
CA2346868A1 (fr) 2000-04-20
JP2006298945A (ja) 2006-11-02
CY1107874T1 (el) 2013-06-19
TR200101088T2 (tr) 2001-10-22
ATE382345T1 (de) 2008-01-15
TW577738B (en) 2004-03-01
CN1196481C (zh) 2005-04-13
NO327285B1 (no) 2009-06-02
HK1040920B (zh) 2005-07-29
WO2000021525A2 (fr) 2000-04-20
IL142375A (en) 2012-01-31
MY121105A (en) 2005-12-30
AR069281A2 (es) 2010-01-13
DE69937891T2 (de) 2008-12-11
NO20011695D0 (no) 2001-04-04
DE69937891D1 (de) 2008-02-14
SK286595B6 (sk) 2009-01-07
ZA200103001B (en) 2002-07-11
JP4938383B2 (ja) 2012-05-23
HUP0104268A3 (en) 2002-06-28
CN1328454A (zh) 2001-12-26
KR20010080156A (ko) 2001-08-22
WO2000021525A3 (fr) 2000-08-10
JP2002527388A (ja) 2002-08-27
PL348109A1 (en) 2002-05-06
ES2297936T3 (es) 2008-05-01
CA2346868C (fr) 2008-09-09
PT1121116E (pt) 2008-03-12
HUP0104268A2 (hu) 2002-04-29
AR020780A1 (es) 2002-05-29
HK1040920A1 (en) 2002-06-28
CO5140079A1 (es) 2002-03-22
EP1121116B1 (fr) 2008-01-02
SK286596B6 (sk) 2009-01-07
NO20011695L (no) 2001-05-30
NZ511010A (en) 2003-10-31
IL142375A0 (en) 2002-03-10
RU2259826C2 (ru) 2005-09-10
KR100517090B1 (ko) 2005-09-27

Similar Documents

Publication Publication Date Title
ID29350A (id) Komposisi farmasi untuk pelepasan terus menerus dan metode pelepasan zat aktif farmasi
NO20012168D0 (no) Innretning for regulert avgivelse av aktive stoffer
ID28783A (id) Komposisi farmasi untuk pelepasan termodifikasi dari pemeka insulin dan zat antidiabetes lain
NO2011010I1 (no) Naproksen- og esomeprazoltabletter med modifisert frisetting
ATE516812T1 (de) Pharmazeutische formulierungen zur anhaltenden arzneimittelfreisetzung
ID26099A (id) Turunan amida dan antagonis nosiseptin
EE9800383A (et) Meetod bioloogiliselt sobivate biodegradeeruvate mikroosakeste valmistamiseks, mikroosakesed ja nendest koosnev materjal, farmatseutiline kompositsioon ning mikroosakeste kasutamine
ID26964A (id) Komposisi dan metode untuk pengaturan pengaktifan limfosit
ID26848A (id) Koupling untuk gigi-gigi eksapator dan sejenisnya
EE200100714A (et) Farmatseutiliste ravimvormide pihustamissüsteemidja -meetodid
ZA9811799B (en) Solid galenic form of the controlled release tablet type for the instant and then prolonged release of one or more active substances
ID26104A (id) Metoda-metoda dan bahan-bahan untuk mengobati dan mencegah radang jaringan mukosa
CY2009015I1 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID21019A (id) Turunan pirazol, pembuatannya dan penggunaannya dalam sediaan farmasi
DK1043977T3 (da) Oral farmaceutisk doseringsform baseret på pulserende frigørelse
ATE234078T1 (de) Pharmazeutische omeprazol-formulierung
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
ID24490A (id) Metode untuk menggunakan dan metode pembuatan tabung oven-pijar
DE69935193D1 (de) Tomografisches Verfahren und System
ID24196A (id) Komposisi dan penggunaan
ID26707A (id) Katalisator untuk produksi-olefin dan metode produksi-olefin
ID24165A (id) Proses-proses dan zat antara untuk membuat antifolat
NO996584D0 (no) brukshjelp for absorberende gjenstand til engangsbruk
ID28261A (id) Alat penghancur dan metoda penghancuran